Measurement Endpoints: Acute: GH levels via immunoassay (15 min 4 hours) Intermediate: IGF-1 levels (4-24 hours) Chronic: Body composition, growth markers, tissue analyses (days-weeks) Potential Research Questions: The Ipamorelin + Tesamorelin Blend enables investigation of numerous research questions: What is the magnitude of synergy between GHRH and GHRP pathways at varying amount combinations
Nez F, Taura J, Camacho J, Lpez-Cano M, Fernndez-Dueas V, Castro N, et al
The efficacy and effectiveness of oral semaglutide in reducing HbA1c levels and body weight, coupled with its favorable clinical profile, positions it as an optimal choice for people with T2D
Back Gilbert, B, Rosenthal, D (21 Jan 2024) 'The complete history & strategy of Novo Nordisk: Novo Nordisk (Ozempic)', Acquired podcast, Season 14, Episode 1